Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by topic
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by topic
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
More
You are here
Home
T cell anergy/exhaustion
Email alerts
T cell anergy/exhaustion
Mechanism of tumor rejection with doublets of CTLA-4, PD-1/PD-L1, or IDO blockade involves restored IL-2 production and proliferation of CD8
+
T cells directly within the tumor microenvironment
Stefani
Spranger
,
Holly K
Koblish
,
Brendan
Horton
,
Peggy A
Scherle
,
Robert
Newton
,
Thomas F
Gajewski
Journal for ImmunoTherapy of Cancer
Dec 2014,
2
(1)
3;
DOI:
10.1186/2051-1426-2-3
Special collections
COVID-19
(17)
Editor's choice
JITC
Basic Tumor Immunology
(103)
Case Reports
(20)
Clinical Trials Monitor
(1)
Clinical/Translational Cancer Immunotherapy
(186)
Commentary/Editorials
(19)
COVID-19 and Cancer Immunotherapy
Emerging Immunotherapeutic Agents
(5)
Guidelines and Consensus Statements
Immune Cell Therapies and Immune Cell Engineering
(38)
Immune Checkpoint Series
(9)
Immune Checkpoints - Beyond PD-1
Immune Monitoring Technology Primers
(12)
Immunotherapy Biomarkers
(64)
Microbial-Based Cancer Immunotherapy
(4)
Oncolytic and Local Immunotherapy
(20)
Position Articles and Guidelines
(26)
Reviews
(37)
Open access
(1433)
Press releases